Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Apellis Pharmaceuticals (APLS) Cash from Investing Activities (2020 - 2025)

Apellis Pharmaceuticals filings provide 6 years of Cash from Investing Activities readings, the most recent being -$108000.0 for Q4 2025.

  • For the quarter ending Q4 2025, Cash from Investing Activities fell 440.0% year-over-year to -$108000.0, compared with a TTM value of -$313000.0 through Dec 2025, up 22.33%, and an annual FY2025 reading of -$313000.0, up 22.33% over the prior year.
  • Cash from Investing Activities hit -$108000.0 in Q4 2025 for Apellis Pharmaceuticals, up from -$148000.0 in the prior quarter.
  • The five-year high for Cash from Investing Activities was $179.6 million in Q3 2021, with the low at -$271.9 million in Q1 2022.
  • Median Cash from Investing Activities over the past 5 years was -$47000.0 (2023), compared with a mean of $16.1 million.
  • The sharpest move saw Cash from Investing Activities surged 93484.62% in 2021, then crashed 600.0% in 2024.
  • Year by year, Cash from Investing Activities stood at $85.0 million in 2021, then skyrocketed by 46.07% to $124.1 million in 2022, then tumbled by 100.0% to $4000.0 in 2023, then tumbled by 600.0% to -$20000.0 in 2024, then tumbled by 440.0% to -$108000.0 in 2025.
  • According to Business Quant data, Cash from Investing Activities over the past three periods came in at -$108000.0, -$148000.0, and -$49000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.